Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2006
02/02/2006WO2005118773A3 Apparatus and methods for multiplex analyses
02/02/2006WO2005117532A3 Method for improved breast milk feeding to reduce the risk of allergy
02/02/2006WO2005113812A8 Collections of matched biological reagents and methods for identifying matched reagents
02/02/2006WO2005107782A3 Use of a modulator of gene expression in the treatment of cancer
02/02/2006WO2005098035A3 Method for the quantification of methylated dna
02/02/2006WO2005093411A3 Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxigenase and methods of using the same
02/02/2006WO2005090966A3 Diagnostics and therapeutics for diseases associated with peroxisome proliferator activated receptor delta (ppard)
02/02/2006WO2005086674A8 Brhf1 as a cancer diagnostic marker
02/02/2006WO2005085818A3 Method and device for the measurement and on-line characterisation of a biomass
02/02/2006WO2005066369A3 Nucleic acid sequencing by raman monitoring of uptake of nucleotides during molecular replication
02/02/2006WO2005051413A3 Disease associated genes
02/02/2006WO2005047245A3 Fluorescence assays with improved blocking groups
02/02/2006WO2005041896A3 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
02/02/2006WO2005033664A3 METHODS FOR IDENTIFYING INHIBITORS OF STEROL 14-alpha-DEMETHYLASE
02/02/2006WO2005014846A3 Methods for identifying risk of breast cancer and treatments thereof
02/02/2006WO2005003721A3 Enzyme activity assays on protein microarrays
02/02/2006WO2005003301A3 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
02/02/2006WO2004101753A3 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
02/02/2006WO2004089190A3 Methods and probes for identifying vulnerable plaque
02/02/2006WO2004083454A8 Wheel motion control input device for animation system
02/02/2006WO2004060301A3 Novel compositions and methods in cancer
02/02/2006WO2003102166A3 Novel flavivirus antigens
02/02/2006WO2002094990A3 Receptors and membrane-associated proteins
02/02/2006US20060026720 Plant proteins
02/02/2006US20060026700 Tissue specific genes and gene clusters
02/02/2006US20060026699 Methods and compositions for identification of genomic sequences
02/02/2006US20060025582 Promoter sequences for corticotropin releasing-factor receptor CRF2alpha and method of identifying agents that alter the activity of the promoter sequences
02/02/2006US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression
02/02/2006US20060025373 Modulation of glucocorticoid receptor expression
02/02/2006US20060025363 Use of antisense oligonucleotides for the treatment of degenerative skin conditions
02/02/2006US20060025362 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
02/02/2006US20060025360 Human cervical cancer protooncogene and protein encoded therein
02/02/2006US20060025337 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
02/02/2006US20060024844 Method for the idenification of ligands
02/02/2006US20060024820 Chromosome-based platforms
02/02/2006US20060024811 Storing data encoded DNA in living organisms
02/02/2006US20060024809 Ceramidase gene
02/02/2006US20060024808 Covalent tethering of functional groups to proteins and substrates therefor
02/02/2006US20060024807 Kinase nucleic acids and polypeptides encoded by these nucleic acids; kinase inhibiitor design and indentifying inhibitors
02/02/2006US20060024806 Mycolactone locus: an assembly line for producing novel polyketides, therapeutic and prophylactic uses
02/02/2006US20060024804 Isoforms isolated and purified from mammalian colostrum
02/02/2006US20060024799 Method for linear mRNA amplification
02/02/2006US20060024797 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
02/02/2006US20060024795 Interferon-Like molecules and uses thereof
02/02/2006US20060024792 G-protein coupled receptors
02/02/2006US20060024785 Having mutations in the Kinase domain region (KDR) and/or the FMS-like Tyrosine-Kinase region (FLT-1), said variants exhibiting modified binding characteristics at said regions compared with native VEGF; stimulates vasculogenesis or angiogenesis; wound healing
02/02/2006US20060024776 Magnetic particle capture of whole intact organisms from clinical samples
02/02/2006US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase
02/02/2006US20060024774 Sensor array
02/02/2006US20060024773 Method for measuring intracellular gene transcription using blue luciferase from dinoflagellate
02/02/2006US20060024756 Methods and algorithms for cell enumeration in low-cost cytometer
02/02/2006US20060024754 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
02/02/2006US20060024749 Measuring the level of NR2A and/or NR2B NMDA receptor within three hours after stroke onset; for diagnosing stroke in an emergency room setting
02/02/2006US20060024745 Variants of factor XllA
02/02/2006US20060024743 Probes labeled with energy transfer coupled dyes
02/02/2006US20060024742 Immunogenic polypeptide of given sequence; diagnosis or treatment of conditions resulting from gene over-expression
02/02/2006US20060024741 Support for fixing nucleotide and process for producing the same
02/02/2006US20060024740 Detection of wheat and barley fungal pathogens which are resistant to certain fungicides using the polymerase chain reaction
02/02/2006US20060024739 C. elegans gro-1 gene
02/02/2006US20060024738 Site- or sequence-specific process for cleaving analytes and library of analytes
02/02/2006US20060024737 Endocnucleases; real time detection; enzyme resistance; chimera
02/02/2006US20060024736 Methods of detection employing immuno-Q-Amp technology
02/02/2006US20060024735 Chimeric nucleic acid constructs and compositions comprising sets of nucleic acid constructs
02/02/2006US20060024734 MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
02/02/2006US20060024733 Storing data encoded DNA in living organisms
02/02/2006US20060024732 Microdevices having a preferential axis of magnetization and uses thereof
02/02/2006US20060024731 Forming a ligation product on a target nucleotide sequence; amplifying the product; detecting the amplified product, and identifying the target nucleotide sequence; multiplex methods
02/02/2006US20060024730 TF binding compounds
02/02/2006US20060024729 Mechanosensitive mammalian potassium channels activatable by polyunsaturated fatty acids and the use of said channels in drug screening
02/02/2006US20060024728 GM-CSF and/or defensin protein expression regulators in epithelial cells comprising ETS transcription factor or gene encoding the same
02/02/2006US20060024727 Antisense modulation of C-reactive protein expression
02/02/2006US20060024726 Position dependent recognition of GNN nucleotide triplets by zinc fingers
02/02/2006US20060024725 Oncofetal fibronectin as a marker for pregnancy-related indications
02/02/2006US20060024724 Oncofetal fibronectin as a marker for health and disease
02/02/2006US20060024723 Methods for detecting oncofetal fibronectin
02/02/2006US20060024722 Samples for detection of oncofetal fibronectin and uses thereof
02/02/2006US20060024721 Assay and kit for analyzing gene expression
02/02/2006US20060024720 Multiplex data acquisition modes for ion mobility-mass spectrometry
02/02/2006US20060024719 Determining MRP-8/14 protein or haptoglobin presence in fluid or tissue sample in patient without interfering condition such as cancer, meningitis, pneumonia, tuberculosis, septicemia, rheumatic arthritis, inflammatory bowel disease, AIDS; or periodontal, skin or gastrointestinal disorders; immunoassay
02/02/2006US20060024718 Systems and methods of analyzing nucleic acid polymers and related components
02/02/2006US20060024717 Apparatus comprising data analysis module operative to receive one or more signals from the detector for use in determining order of preferential nucleotide sequence
02/02/2006US20060024716 Systems and methods of analyzing nucleic acid polymers and related components
02/02/2006US20060024715 Methods for genotyping polymorphisms in humans
02/02/2006US20060024714 Compositions and methods for detecting and quantitating polynucleotide sequences
02/02/2006US20060024713 Synthesis of oligomers in arrays
02/02/2006US20060024712 Separation of nucleic acid
02/02/2006US20060024711 Methods for nucleic acid amplification and sequence determination
02/02/2006US20060024710 Method and device for identifying germs
02/02/2006US20060024709 Methods for nucleic acid manipulation
02/02/2006US20060024708 Porcine sulfotransferase 2A1 polynucleotide sequence, protein, and methods of use for same
02/02/2006US20060024707 Luminescent polymers and methods of use thereof
02/02/2006US20060024706 Transforming growth factor beta 1 (TGFbeta1) haplotypes and prediction of susceptibility for immunological disorders
02/02/2006US20060024705 Molecular analysis of hair follicles for disease
02/02/2006US20060024704 Detection of markers in nascent proteins
02/02/2006US20060024703 Library on a slide and the use thereof
02/02/2006US20060024702 Device, system, and method for detecting a target molecule in a sample
02/02/2006US20060024701 Methods and reagents for the isolation of nucleic acids
02/02/2006US20060024700 determining whether a hepatitis C virus-infected human has an increased risk for developing liver fibrosis, comprising testing nucleic acid from the human for a polymorphism in gene TLR4 as represented by position 101 of SEQ ID NO: 18973 or its complement
02/02/2006US20060024699 Method for evaluating a substance capable of effecting on endoplasmic reticulum stress-and/or amyloid beta-induced apoptosis
02/02/2006US20060024698 Exposing the DNA molecule to an amount of a pure preparation of DdrA protein effective to decrease exonuclease damage in relation to natural exonuclease damage that would occur in the absence of DdrA